EVO101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EVO101, covering 2024-12-11 to 2024-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% [EARLY_Phase 1]